STOCK TITAN

[Form 4] Acushnet Holdings Corp. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

Walgreens Boots Alliance (WBA) has reached the decisive shareholder-approval stage of its going-private deal with Sycamore Partners-backed Blazing Star Parent. Amendment No. 4 to Schedule 13E-3 confirms that, at the 11 July 2025 special meeting, both required votes were secured: (i) a majority of all outstanding common shares and (ii) a majority of unaffiliated shares supported the Agreement and Plan of Merger dated 6 March 2025.

Key economics: Each outstanding WBA share will be converted into the right to receive (a) $11.45 in cash plus (b) one Divested Asset Proceed Right (DAP Right), whose terms are governed by a separate agreement. Treasury, parent-owned and dissenting shares are excluded.

Post-closing structure: Upon effectiveness, WBA will merge with Blazing Star Merger Sub and become a wholly-owned subsidiary of Blazing Star Parent; WBA common stock will cease public trading.

Sponsor & insider arrangements: • Long-time shareholder Stefano Pessina (through Alliance Santé entities) owns 16.8 % voting power and has signed both a Voting Agreement and a Reinvestment Agreement to roll over cash proceeds into the new private holding companies. • The board unanimously approved the deal, with Pessina and director John Lederer recused.

Next steps: With shareholder approval in hand, closing now depends on remaining customary conditions (e.g., regulatory clearances, financing draw-down) outlined in the Merger Agreement. After closing, public investors will hold no equity interest; liquidity is limited to the cash/DAP consideration.

Walgreens Boots Alliance (WBA) ha raggiunto la fase decisiva di approvazione da parte degli azionisti per la sua operazione di privatizzazione con Blazing Star Parent, sostenuta da Sycamore Partners. L'Emendamento n. 4 al Schedule 13E-3 conferma che, durante l'assemblea speciale dell'11 luglio 2025, sono stati ottenuti entrambi i voti richiesti: (i) la maggioranza di tutte le azioni ordinarie in circolazione e (ii) la maggioranza delle azioni non affiliate hanno approvato l'Accordo e il Piano di Fusione datato 6 marzo 2025.

Dettagli economici principali: Ogni azione WBA in circolazione sarà convertita nel diritto di ricevere (a) 11,45 $ in contanti più (b) un Divested Asset Proceed Right (DAP Right), i cui termini sono regolati da un accordo separato. Le azioni di tesoreria, di proprietà della società madre e quelle dissenzienti sono escluse.

Struttura post-fusione: Al momento dell’efficacia, WBA si fonderà con Blazing Star Merger Sub e diventerà una controllata interamente posseduta da Blazing Star Parent; le azioni ordinarie WBA cesseranno di essere quotate in borsa.

Accordi con sponsor e insider: • Il socio di lunga data Stefano Pessina (attraverso entità Alliance Santé) detiene il 16,8% del potere di voto e ha firmato sia un Accordo di Voto sia un Accordo di Reinvestimento per reinvestire i proventi in contanti nelle nuove holding private. • Il consiglio di amministrazione ha approvato all’unanimità l’operazione, con Pessina e il direttore John Lederer che si sono astenuti.

Prossimi passi: Con l’approvazione degli azionisti ottenuta, la chiusura dipende ora dalle condizioni consuete residue (ad esempio, autorizzazioni regolamentari, erogazione del finanziamento) indicate nell’Accordo di Fusione. Dopo la chiusura, gli investitori pubblici non avranno alcuna partecipazione azionaria; la liquidità sarà limitata al corrispettivo in contanti e DAP.

Walgreens Boots Alliance (WBA) ha alcanzado la etapa decisiva de aprobación por parte de los accionistas para su acuerdo de privatización con Blazing Star Parent, respaldado por Sycamore Partners. La Enmienda No. 4 al Schedule 13E-3 confirma que, en la reunión especial del 11 de julio de 2025, se obtuvieron ambos votos requeridos: (i) la mayoría de todas las acciones ordinarias en circulación y (ii) la mayoría de las acciones no afiliadas apoyaron el Acuerdo y Plan de Fusión fechado el 6 de marzo de 2025.

Aspectos económicos clave: Cada acción en circulación de WBA se convertirá en el derecho a recibir (a) 11,45 $ en efectivo más (b) un Divested Asset Proceed Right (DAP Right), cuyos términos están regulados por un acuerdo separado. Se excluyen acciones en tesorería, propiedad de la matriz y disidentes.

Estructura post-cierre: Al entrar en vigor, WBA se fusionará con Blazing Star Merger Sub y se convertirá en una subsidiaria de propiedad total de Blazing Star Parent; las acciones ordinarias de WBA dejarán de cotizar públicamente.

Acuerdos con patrocinadores e internos: • El accionista de larga data Stefano Pessina (a través de entidades Alliance Santé) posee el 16,8 % del poder de voto y ha firmado tanto un Acuerdo de Votación como un Acuerdo de Reinversión para reinvertir los ingresos en efectivo en las nuevas sociedades privadas. • La junta directiva aprobó la operación por unanimidad, con Pessina y el director John Lederer recusados.

Próximos pasos: Con la aprobación de los accionistas en mano, el cierre ahora depende de las condiciones habituales restantes (por ejemplo, autorizaciones regulatorias, desembolso de financiamiento) descritas en el Acuerdo de Fusión. Tras el cierre, los inversores públicos no tendrán participación accionaria; la liquidez se limita a la contraprestación en efectivo/DAP.

Walgreens Boots Alliance(WBA)는 Sycamore Partners가 지원하는 Blazing Star Parent와의 비상장 전환 거래에 대한 주주 승인 단계를 마무리했습니다. Schedule 13E-3의 수정안 4호는 2025년 7월 11일 특별 주주총회에서 두 가지 필수 투표가 확보되었음을 확인합니다: (i) 모든 발행 보통주 과반수, (ii) 비계열 주식 과반수가 2025년 3월 6일자 합병 계약 및 계획을 지지했습니다.

주요 경제 조건: 보유 중인 WBA 주식 한 주당 (a) 현금 11.45달러와 (b) 별도의 계약에 의해 조건이 정해진 Divested Asset Proceed Right(DAP 권리) 1개를 받을 권리로 전환됩니다. 자사주, 모회사 소유주식, 반대 주식은 제외됩니다.

거래 종료 후 구조: 효력 발생 시 WBA는 Blazing Star Merger Sub와 합병되어 Blazing Star Parent의 완전 자회사가 되며, WBA 보통주는 상장 거래가 중단됩니다.

스폰서 및 내부자 계약: • 오랜 주주인 Stefano Pessina는 Alliance Santé 법인을 통해 16.8%의 의결권을 보유하고 있으며, 현금 수익금을 새로운 비상장 지주회사에 재투자하기 위한 투표 계약 및 재투자 계약에 서명했습니다. • 이사회는 만장일치로 거래를 승인했으며, Pessina와 이사 John Lederer는 회피했습니다.

다음 단계: 주주 승인을 받은 후, 거래 종결은 합병 계약에 명시된 일반적인 조건(예: 규제 승인, 자금 조달 실행) 충족 여부에 달려 있습니다. 종결 후 공공 투자자는 지분을 보유하지 않으며, 유동성은 현금/DAP 보상에 국한됩니다.

Walgreens Boots Alliance (WBA) a atteint l’étape décisive d’approbation par les actionnaires de son opération de privatisation avec Blazing Star Parent, soutenu par Sycamore Partners. L’amendement n°4 au Schedule 13E-3 confirme que, lors de l’assemblée spéciale du 11 juillet 2025, les deux votes requis ont été obtenus : (i) la majorité de toutes les actions ordinaires en circulation et (ii) la majorité des actions non affiliées ont approuvé l’Accord et le Plan de Fusion datés du 6 mars 2025.

Principaux aspects économiques : Chaque action WBA en circulation sera convertie en droit de recevoir (a) 11,45 $ en espèces plus (b) un Divested Asset Proceed Right (DAP Right), dont les termes sont régis par un accord distinct. Les actions de trésorerie, détenues par la société mère ou dissidentes sont exclues.

Structure post-clôture : À l’entrée en vigueur, WBA fusionnera avec Blazing Star Merger Sub et deviendra une filiale à 100 % de Blazing Star Parent ; les actions ordinaires WBA cesseront d’être cotées en bourse.

Accords avec le sponsor et les initiés : • L’actionnaire de longue date Stefano Pessina (via les entités Alliance Santé) détient 16,8 % du pouvoir de vote et a signé un accord de vote ainsi qu’un accord de réinvestissement pour réinjecter les produits en espèces dans les nouvelles sociétés holding privées. • Le conseil d’administration a approuvé à l’unanimité l’opération, Pessina et le directeur John Lederer s’étant récusés.

Étapes suivantes : Avec l’approbation des actionnaires obtenue, la clôture dépend désormais des conditions habituelles restantes (par exemple, autorisations réglementaires, décaissement du financement) mentionnées dans l’Accord de Fusion. Après la clôture, les investisseurs publics ne détiendront plus de participation ; la liquidité sera limitée à la contrepartie en espèces/DAP.

Walgreens Boots Alliance (WBA) hat die entscheidende Aktionärszustimmung für den geplanten Börsenrückzug mit Blazing Star Parent, unterstützt von Sycamore Partners, erreicht. Nachtrag Nr. 4 zum Schedule 13E-3 bestätigt, dass bei der außerordentlichen Hauptversammlung am 11. Juli 2025 beide erforderlichen Mehrheiten erreicht wurden: (i) die Mehrheit aller ausstehenden Stammaktien und (ii) die Mehrheit der nicht verbundenen Aktien stimmten dem am 6. März 2025 datierten Fusionsvertrag zu.

Wesentliche wirtschaftliche Bedingungen: Jede ausstehende WBA-Aktie wird in das Recht umgewandelt, (a) 11,45 $ in bar sowie (b) ein Divested Asset Proceed Right (DAP Right) zu erhalten, dessen Bedingungen in einer separaten Vereinbarung geregelt sind. Eigene Aktien, Muttergesellschaftsanteile und abweichende Stimmen sind ausgeschlossen.

Struktur nach Abschluss: Nach Wirksamwerden fusioniert WBA mit Blazing Star Merger Sub und wird eine hundertprozentige Tochtergesellschaft von Blazing Star Parent; die WBA-Stammaktien werden nicht mehr öffentlich gehandelt.

Vereinbarungen mit Sponsor und Insidern: • Der langjährige Aktionär Stefano Pessina (über Alliance Santé-Einheiten) hält 16,8 % der Stimmrechte und hat sowohl eine Stimmrechtsvereinbarung als auch eine Reinvestitionsvereinbarung unterzeichnet, um die Barausschüttungen in die neuen privaten Holdinggesellschaften zu reinvestieren. • Der Vorstand genehmigte die Transaktion einstimmig, wobei Pessina und Direktor John Lederer sich der Abstimmung enthielten.

Nächste Schritte: Mit der Aktionärszustimmung in der Tasche hängt der Abschluss nun von den verbleibenden üblichen Bedingungen ab (z. B. behördliche Genehmigungen, Finanzierungsauszahlung), die im Fusionsvertrag festgelegt sind. Nach Abschluss halten öffentliche Investoren keine Beteiligungen mehr; die Liquidität beschränkt sich auf die Bar-/DAP-Zahlung.

Positive
  • Shareholder approval achieved, satisfying a critical closing condition and reducing deal-completion risk.
  • $11.45 per share cash payout provides certainty of value to holders upon closing.
  • Insiders’ reinvestment agreement signals ongoing commitment to the business post-transaction.
Negative
  • Public shares will be delisted, eliminating ongoing liquidity and market participation for current investors.
  • Value of DAP Rights is uncertain; future proceeds depend on divestiture outcomes not yet quantified.

Insights

TL;DR: Shareholder nod clears $11.45-per-share cash + DAP take-private; regulatory/financing closing conditions remain.

The affirmative vote by both overall and unaffiliated shareholders satisfies the most material closing condition under the Merger Agreement. Cash consideration is fixed, limiting price risk for holders awaiting completion; the contingent DAP Right offers upside tied to asset divestiture proceeds but carries valuation uncertainty. Board recusal of related directors and dual fairness opinions (Centerview, Morgan Stanley) strengthen procedural safeguards, reducing litigation risk. Financing appears well mapped via multiple commitment letters, lowering deal-execution risk. Overall impact: moderately positive as the transaction advances toward consummation.

TL;DR: Liquidity event locked-in; public shareholders trade equity upside for $11.45 cash plus contingent right.

For arbitrageurs, the filing removes voting uncertainty, shifting focus to spread-to-close and regulatory timeline. Income-oriented investors lose future dividend streams once shares delist. Without disclosed market-price premium data, risk-adjusted return hinges on timing and DAP Right valuation. The reinvestment by Pessina aligns insiders with post-deal value creation but eliminates minority participation. Impact on existing portfolios is neutral to slightly positive: certainty of cash exit but forfeiture of long-term public market upside.

Walgreens Boots Alliance (WBA) ha raggiunto la fase decisiva di approvazione da parte degli azionisti per la sua operazione di privatizzazione con Blazing Star Parent, sostenuta da Sycamore Partners. L'Emendamento n. 4 al Schedule 13E-3 conferma che, durante l'assemblea speciale dell'11 luglio 2025, sono stati ottenuti entrambi i voti richiesti: (i) la maggioranza di tutte le azioni ordinarie in circolazione e (ii) la maggioranza delle azioni non affiliate hanno approvato l'Accordo e il Piano di Fusione datato 6 marzo 2025.

Dettagli economici principali: Ogni azione WBA in circolazione sarà convertita nel diritto di ricevere (a) 11,45 $ in contanti più (b) un Divested Asset Proceed Right (DAP Right), i cui termini sono regolati da un accordo separato. Le azioni di tesoreria, di proprietà della società madre e quelle dissenzienti sono escluse.

Struttura post-fusione: Al momento dell’efficacia, WBA si fonderà con Blazing Star Merger Sub e diventerà una controllata interamente posseduta da Blazing Star Parent; le azioni ordinarie WBA cesseranno di essere quotate in borsa.

Accordi con sponsor e insider: • Il socio di lunga data Stefano Pessina (attraverso entità Alliance Santé) detiene il 16,8% del potere di voto e ha firmato sia un Accordo di Voto sia un Accordo di Reinvestimento per reinvestire i proventi in contanti nelle nuove holding private. • Il consiglio di amministrazione ha approvato all’unanimità l’operazione, con Pessina e il direttore John Lederer che si sono astenuti.

Prossimi passi: Con l’approvazione degli azionisti ottenuta, la chiusura dipende ora dalle condizioni consuete residue (ad esempio, autorizzazioni regolamentari, erogazione del finanziamento) indicate nell’Accordo di Fusione. Dopo la chiusura, gli investitori pubblici non avranno alcuna partecipazione azionaria; la liquidità sarà limitata al corrispettivo in contanti e DAP.

Walgreens Boots Alliance (WBA) ha alcanzado la etapa decisiva de aprobación por parte de los accionistas para su acuerdo de privatización con Blazing Star Parent, respaldado por Sycamore Partners. La Enmienda No. 4 al Schedule 13E-3 confirma que, en la reunión especial del 11 de julio de 2025, se obtuvieron ambos votos requeridos: (i) la mayoría de todas las acciones ordinarias en circulación y (ii) la mayoría de las acciones no afiliadas apoyaron el Acuerdo y Plan de Fusión fechado el 6 de marzo de 2025.

Aspectos económicos clave: Cada acción en circulación de WBA se convertirá en el derecho a recibir (a) 11,45 $ en efectivo más (b) un Divested Asset Proceed Right (DAP Right), cuyos términos están regulados por un acuerdo separado. Se excluyen acciones en tesorería, propiedad de la matriz y disidentes.

Estructura post-cierre: Al entrar en vigor, WBA se fusionará con Blazing Star Merger Sub y se convertirá en una subsidiaria de propiedad total de Blazing Star Parent; las acciones ordinarias de WBA dejarán de cotizar públicamente.

Acuerdos con patrocinadores e internos: • El accionista de larga data Stefano Pessina (a través de entidades Alliance Santé) posee el 16,8 % del poder de voto y ha firmado tanto un Acuerdo de Votación como un Acuerdo de Reinversión para reinvertir los ingresos en efectivo en las nuevas sociedades privadas. • La junta directiva aprobó la operación por unanimidad, con Pessina y el director John Lederer recusados.

Próximos pasos: Con la aprobación de los accionistas en mano, el cierre ahora depende de las condiciones habituales restantes (por ejemplo, autorizaciones regulatorias, desembolso de financiamiento) descritas en el Acuerdo de Fusión. Tras el cierre, los inversores públicos no tendrán participación accionaria; la liquidez se limita a la contraprestación en efectivo/DAP.

Walgreens Boots Alliance(WBA)는 Sycamore Partners가 지원하는 Blazing Star Parent와의 비상장 전환 거래에 대한 주주 승인 단계를 마무리했습니다. Schedule 13E-3의 수정안 4호는 2025년 7월 11일 특별 주주총회에서 두 가지 필수 투표가 확보되었음을 확인합니다: (i) 모든 발행 보통주 과반수, (ii) 비계열 주식 과반수가 2025년 3월 6일자 합병 계약 및 계획을 지지했습니다.

주요 경제 조건: 보유 중인 WBA 주식 한 주당 (a) 현금 11.45달러와 (b) 별도의 계약에 의해 조건이 정해진 Divested Asset Proceed Right(DAP 권리) 1개를 받을 권리로 전환됩니다. 자사주, 모회사 소유주식, 반대 주식은 제외됩니다.

거래 종료 후 구조: 효력 발생 시 WBA는 Blazing Star Merger Sub와 합병되어 Blazing Star Parent의 완전 자회사가 되며, WBA 보통주는 상장 거래가 중단됩니다.

스폰서 및 내부자 계약: • 오랜 주주인 Stefano Pessina는 Alliance Santé 법인을 통해 16.8%의 의결권을 보유하고 있으며, 현금 수익금을 새로운 비상장 지주회사에 재투자하기 위한 투표 계약 및 재투자 계약에 서명했습니다. • 이사회는 만장일치로 거래를 승인했으며, Pessina와 이사 John Lederer는 회피했습니다.

다음 단계: 주주 승인을 받은 후, 거래 종결은 합병 계약에 명시된 일반적인 조건(예: 규제 승인, 자금 조달 실행) 충족 여부에 달려 있습니다. 종결 후 공공 투자자는 지분을 보유하지 않으며, 유동성은 현금/DAP 보상에 국한됩니다.

Walgreens Boots Alliance (WBA) a atteint l’étape décisive d’approbation par les actionnaires de son opération de privatisation avec Blazing Star Parent, soutenu par Sycamore Partners. L’amendement n°4 au Schedule 13E-3 confirme que, lors de l’assemblée spéciale du 11 juillet 2025, les deux votes requis ont été obtenus : (i) la majorité de toutes les actions ordinaires en circulation et (ii) la majorité des actions non affiliées ont approuvé l’Accord et le Plan de Fusion datés du 6 mars 2025.

Principaux aspects économiques : Chaque action WBA en circulation sera convertie en droit de recevoir (a) 11,45 $ en espèces plus (b) un Divested Asset Proceed Right (DAP Right), dont les termes sont régis par un accord distinct. Les actions de trésorerie, détenues par la société mère ou dissidentes sont exclues.

Structure post-clôture : À l’entrée en vigueur, WBA fusionnera avec Blazing Star Merger Sub et deviendra une filiale à 100 % de Blazing Star Parent ; les actions ordinaires WBA cesseront d’être cotées en bourse.

Accords avec le sponsor et les initiés : • L’actionnaire de longue date Stefano Pessina (via les entités Alliance Santé) détient 16,8 % du pouvoir de vote et a signé un accord de vote ainsi qu’un accord de réinvestissement pour réinjecter les produits en espèces dans les nouvelles sociétés holding privées. • Le conseil d’administration a approuvé à l’unanimité l’opération, Pessina et le directeur John Lederer s’étant récusés.

Étapes suivantes : Avec l’approbation des actionnaires obtenue, la clôture dépend désormais des conditions habituelles restantes (par exemple, autorisations réglementaires, décaissement du financement) mentionnées dans l’Accord de Fusion. Après la clôture, les investisseurs publics ne détiendront plus de participation ; la liquidité sera limitée à la contrepartie en espèces/DAP.

Walgreens Boots Alliance (WBA) hat die entscheidende Aktionärszustimmung für den geplanten Börsenrückzug mit Blazing Star Parent, unterstützt von Sycamore Partners, erreicht. Nachtrag Nr. 4 zum Schedule 13E-3 bestätigt, dass bei der außerordentlichen Hauptversammlung am 11. Juli 2025 beide erforderlichen Mehrheiten erreicht wurden: (i) die Mehrheit aller ausstehenden Stammaktien und (ii) die Mehrheit der nicht verbundenen Aktien stimmten dem am 6. März 2025 datierten Fusionsvertrag zu.

Wesentliche wirtschaftliche Bedingungen: Jede ausstehende WBA-Aktie wird in das Recht umgewandelt, (a) 11,45 $ in bar sowie (b) ein Divested Asset Proceed Right (DAP Right) zu erhalten, dessen Bedingungen in einer separaten Vereinbarung geregelt sind. Eigene Aktien, Muttergesellschaftsanteile und abweichende Stimmen sind ausgeschlossen.

Struktur nach Abschluss: Nach Wirksamwerden fusioniert WBA mit Blazing Star Merger Sub und wird eine hundertprozentige Tochtergesellschaft von Blazing Star Parent; die WBA-Stammaktien werden nicht mehr öffentlich gehandelt.

Vereinbarungen mit Sponsor und Insidern: • Der langjährige Aktionär Stefano Pessina (über Alliance Santé-Einheiten) hält 16,8 % der Stimmrechte und hat sowohl eine Stimmrechtsvereinbarung als auch eine Reinvestitionsvereinbarung unterzeichnet, um die Barausschüttungen in die neuen privaten Holdinggesellschaften zu reinvestieren. • Der Vorstand genehmigte die Transaktion einstimmig, wobei Pessina und Direktor John Lederer sich der Abstimmung enthielten.

Nächste Schritte: Mit der Aktionärszustimmung in der Tasche hängt der Abschluss nun von den verbleibenden üblichen Bedingungen ab (z. B. behördliche Genehmigungen, Finanzierungsauszahlung), die im Fusionsvertrag festgelegt sind. Nach Abschluss halten öffentliche Investoren keine Beteiligungen mehr; die Liquidität beschränkt sich auf die Bar-/DAP-Zahlung.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Misto Holdings Corp.

(Last) (First) (Middle)
35 BOMUN-RO, SEONGBUK-GU
9F, 10F

(Street)
SEOUL M5 02873

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Acushnet Holdings Corp. [ GOLF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/10/2025 S 953,406(1) D $65.5633 29,523,653 I See explanation of responses(2)(3)(4)(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Misto Holdings Corp.

(Last) (First) (Middle)
35 BOMUN-RO, SEONGBUK-GU
9F, 10F

(Street)
SEOUL M5 02873

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Magnus Holdings Co., Ltd.

(Last) (First) (Middle)
35 BOMUN-RO, SEONGBUK-GU
10F

(Street)
SEOUL M5 02873

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. Represents shares sold to Acushnet Holdings Corp. pursuant to the Stock Repurchase Agreement dated December 17, 2024.
2. Magnus Holdings Co., Ltd., directly holds 29,523,653 shares. The sole shareholder of Magnus Holdings Co., Ltd. is Misto Holdings Corp. (formerly, FILA Holdings Corp.). Because of Misto Holdings Corp.'s relationship to Magnus Holdings Co., Ltd., Misto Holdings Corp. may be deemed to beneficially own the shares directly held by Magnus Holdings Co., Ltd.
3. Magnus Holdings Co., Ltd. and Misto Holdings Corp. (together, the "Reporting Persons") disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
4. Solely for the purposes of Section 16 of the Exchange Act, each of Magnus Holdings Co., Ltd. and Misto Holdings Corp. may be deemed a director-by-deputization by virtue of the fact that (i) Yoon Soo Yoon is the Chairman of the Board of Directors of Acushnet Holdings Corp. and the Chairman of Misto Holdings Corp., (ii) Keun Chang Yoon is a Director on the Board of Directors of Acushnet Holdings Corp. and is the President and Chief Executive Officer of Misto Holdings Corp. and (iii) Ho Yeon Lee is a Director on the Board of Directors of Acushnet Holdings Corp. and the CEO of Magnus Holdings Co., Ltd.
5. As a result of their roles at Misto Holdings Corp., each of Yoon Soo Yoon and Keun Chang Yoon may be deemed to be the beneficial owner and have voting and dispositive power with respect to the shares directly held by Magnus Holdings Co., Ltd. Each of Yoon Soo Yoon and Keun Chang Yoon disclaims beneficial ownership over the shares held by Magnus Holdings Co., Ltd., except to the extent of his pecuniary interest therein.
Remarks:
6. The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act.
/s/ Ho Yeon Lee, Chief Executive Officer, Magnus Holdings Co., Ltd. (6) 07/10/2025
/s/ Keun Chang Yoon, Chief Executive Officer and President, Misto Holdings Corp. (6) 07/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Walgreens Boots Alliance (WBA) shareholders approve on 11 July 2025?

They approved the Merger Agreement with Blazing Star Parent, clearing the path for WBA to go private.

How much will WBA investors receive per share?

Each share converts into $11.45 in cash plus one Divested Asset Proceed Right (DAP Right).

What happens to WBA stock after the merger closes?

WBA common stock will be delisted and cease trading; holders will only have the cash and DAP Right consideration.

Who are the key sponsors behind the transaction?

Private-equity firm Sycamore Partners via its Blazing Star entities, alongside investor Stefano Pessina.

Were unaffiliated shareholders required to approve the deal?

Yes. A majority of unaffiliated shares voted in favor, satisfying the unaffiliated vote condition.

What is the purpose of the DAP Right?

It entitles holders to a pro-rata share of proceeds from specified asset divestitures post-closing.
Acushnet Holding

NYSE:GOLF

GOLF Rankings

GOLF Latest News

GOLF Latest SEC Filings

GOLF Stock Data

4.45B
27.55M
54.89%
58.36%
8.7%
Leisure
Sporting & Athletic Goods, Nec
Link
United States
FAIRHAVEN